Evidence map›Paper›PMID 36411471›Full record

ArticleActa neuropathologica communications2022

Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis.

Jesse J Westfall, Wesley N Schwind, Sahibjot Sran, Jason B Navarro, Jeffrey Leonard, Jonathan A Pindrik, Christopher R Pierson, Daniel R Boué, Daniel C Koboldt, Adam P Ostendorf and 4 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jesse J WestfallThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Wesley N SchwindThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Sahibjot SranThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Jason B NavarroThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Jeffrey LeonardDepartment of Neurosurgery, Nationwide Children's Hospital, Columbus, OH, USA.
Jonathan A PindrikDepartment of Neurosurgery, Nationwide Children's Hospital, Columbus, OH, USA.
Christopher R PiersonDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH, USA.
Daniel R BouéDepartment of Pathology, The Ohio State University College of Medicine, Columbus, OH, USA.
Daniel C KoboldtThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Adam P OstendorfDepartment of Neurosurgery, The Ohio State University College of Medicine, Columbus, OH, USA.
Richard K WilsonThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Elaine R MardisThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Katherine E MillerThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA. Katherine.Miller@Nationwidechildrens.org.
Tracy A BedrosianThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Research Building 3, 575 Children's Crossroad, Columbus, OH, 43215, USA. Tracy.Bedrosian@Nationwidechildrens.org.
Nationwide Children's Hospital · USThe Ohio State University · US

Funding

Mapping Somatic TE-derived Transcriptional DiversityK01HG011062 · NHGRI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BEDROSIAN, TRACY ANN · 2020 to 2022
$394k
NHGRI NIH HHS K01 HG011062
6 · The paper itself

Abstract

Rasmussen encephalitis (RE) is a rare childhood neurological disease characterized by progressive unilateral loss of function, hemispheric atrophy and drug-resistant epilepsy. Affected brain tissue shows signs of infiltrating cytotoxic T-cells, microglial activation, and neuronal death, implicating an inflammatory disease process. Recent studies have identified molecular correlates of inflammation in RE, but cell-type-specific mechanisms remain unclear. We used single-nucleus RNA-sequencing (snRNA-seq) to assess gene expression across multiple cell types in brain tissue resected from two children with RE. We found transcriptionally distinct microglial populations enriched in RE compared to two age-matched individuals with unaffected brain tissue and two individuals with Type I focal cortical dysplasia (FCD). Specifically, microglia in RE tissues demonstrated increased expression of genes associated with cytokine signaling, interferon-mediated pathways, and T-cell activation. We extended these findings using spatial proteomic analysis of tissue from four surgical resections to examine expression profiles of microglia within their pathological context. Microglia that were spatially aggregated into nodules had increased expression of dynamic immune regulatory markers (PD-L1, CD14, CD11c), T-cell activation markers (CD40, CD80) and were physically located near distinct CD4+ and CD8+ lymphocyte populations. These findings help elucidate the complex immune microenvironment of RE.

Indexed as

EncephalitisMicrogliaChildHumansInflammationProteomicsCytokine signalingEncephalitisEpilepsyInflammationMicroglial nodulesSingle nucleus RNA-seqSpatial proteomics

Identifiers

PMID36411471
PMCPMC9677917
OpenAlexW4309668368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.